Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Inv. presentation
Solid Biosciences Inc. (SLDB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/23/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/23/2023 10-K Annual Report for the period ended December 31, 2022
03/20/2023 8-K Quarterly results
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/03/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/26/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
01/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
01/09/2023 8-K Investor presentation
Docs: "Solid Biosciences Inc. Presentation January 2023",
"Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer"
12/12/2022 SC 13G Camber Capital Management LP reports a 7.3% stake in Solid Biosciences Inc.
12/09/2022 D Form D - Notice of Exempt Offering of Securities:
12/06/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/05/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/05/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/05/2022 8-K Quarterly results
12/02/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/01/2022 8-K Quarterly results
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
10/28/2022 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
10/27/2022 8-K Quarterly results
10/04/2022 SC 13D/A RA CAPITAL MANAGEMENT, L.P. reports a 11% stake in SOLID BIOSCIENCES INC.
10/03/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/30/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy